Barclays PLC Spdr Ser Tr Spdr S&P Biotech E Call Options Transaction History

Barclays PLC

$377 Billion
Q3 2024

Call Options

24 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 15, 2024	SELL	$90.87 - $102.43 $41.3 Million - $46.6 Million	-455,000 Reduced 69.2%	202,500 $20 Million
Q2 2024 Aug 14, 2024	BUY	$82.22 - $94.12 $28.8 Million - $32.9 Million	349,900 Added 113.75%	657,500 $61 Million
Q1 2024 May 15, 2024	SELL	$87.05 - $102.89 $32.4 Million - $38.3 Million	-372,500 Reduced 54.77%	307,600 $29.2 Million
Q4 2023 Feb 15, 2024	BUY	$64.12 - $90.86 $43.6 Million - $61.8 Million	680,100 New	680,100 $60.7 Million
Q1 2023 May 04, 2023	SELL	$73.13 - $91.97 $2.84 Million - $3.58 Million	-38,900 Reduced 16.15%	202,000 $15.4 Million
Q4 2022 Feb 13, 2023	BUY	$76.72 - $85.66 $18.5 Million - $20.6 Million	240,900 New	240,900 $20 Million
Q2 2022 Aug 12, 2022	SELL	$62.81 - $96.09 $23.3 Million - $35.6 Million	-371,000 Reduced 71.41%	148,500 $11 Million
Q4 2021 Feb 14, 2022	BUY	$108.77 - $134.15 $9.83 Million - $12.1 Million	90,400 Added 21.07%	519,500 $58.2 Million
Q3 2021 Nov 09, 2021	BUY	$118.69 - $138.49 $8.78 Million - $10.2 Million	74,000 Added 20.84%	429,100 $53.9 Million
Q2 2021 Aug 13, 2021	SELL	$122.48 - $139.69 $1.19 Million - $1.35 Million	-9,700 Reduced 2.66%	355,100 $48.1 Million
Q1 2021 May 13, 2021	BUY	$129.36 - $173.99 $24.9 Million - $33.5 Million	192,300 Added 111.48%	364,800 $49.5 Million
Q3 2020 Nov 12, 2020	BUY	$103.87 - $120.36 $17.7 Million - $20.5 Million	170,000 Added 6800.0%	172,500 $19.2 Million
Q2 2020 Aug 12, 2020	SELL	$73.26 - $114.17 $13.3 Million - $20.7 Million	-181,100 Reduced 98.64%	2,500 $280,000
Q1 2020 May 13, 2020	BUY	$65.95 - $98.35 $5.81 Million - $8.66 Million	88,100 Added 92.25%	183,600 $14.2 Million
Q4 2019 Feb 10, 2020	SELL	$74.65 - $98.46 $4.56 Million - $6.02 Million	-61,100 Reduced 39.02%	95,500 $9.08 Million
Q3 2019 Nov 14, 2019	SELL	$76.25 - $83.86 $10.4 Million - $11.4 Million	-135,900 Reduced 46.46%	156,600 $11.9 Million
Q2 2019 Aug 14, 2019	SELL	N/A	-18,900 Reduced 6.07%	292,500 $25.7 Million
Q1 2019 May 15, 2019	SELL	N/A	-213,400 Reduced 40.66%	311,400 $28.2 Million
Q4 2018 Feb 14, 2019	BUY	N/A	289,400 Added 122.94%	524,800 $37.7 Million
Q3 2018 Nov 14, 2018	SELL	N/A	-77,800 Reduced 24.84%	235,400 $22.6 Million
Q2 2018 Aug 14, 2018	BUY	N/A	62,100 Added 24.73%	313,200 $29.8 Million
Q1 2018 May 15, 2018	SELL	N/A	-454,000 Reduced 64.39%	251,100 $22 Million
Q4 2017 Feb 14, 2018	BUY	N/A	400,400 Added 131.41%	705,100 $59.8 Million
Q3 2017 Nov 14, 2017	BUY	N/A	304,700	304,700 $26.4 Million

Others Institutions Holding XBI

# of Institutions

925

Shares Held

101M

Call Options Held

28.4M

Put Options Held

33.4M

Goldman Sachs Group Inc New York, NY

12.7M
Shares

$1.17 Billion
0.21% of portfolio
Jpmorgan Chase & CO New York, NY

12.3M
Shares

$1.13 Billion
0.1% of portfolio
Healthcare Of Ontario Pension Plan Trust Fund Toronto, A6

9.23M
Shares

$847 Million
2.24% of portfolio
Morgan Stanley New York, NY

8.02M
Shares

$736 Million
0.06% of portfolio
Citigroup Inc

7.75M
Shares

$712 Million
0.45% of portfolio

View Full List

About SPDR SER TR SPDR S&P BIOTECH E

Ticker XBI
Sector ETFs
Industry ETFs

More about XBI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account